Sharps Compliance (SMED) Reports Narrower than Expected Q3 Loss
Get Alerts SMED Hot Sheet
Join SI Premium – FREE
Sharps Compliance Corp. (NASDAQ: SMED) reported Q3 loss of $0.04, $0.01 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $4.5 million versus the consensus estimate of $4.62 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Takeda Pharmaceutical Company Limited (TAK) Reports Q3 EPS of JPY308.00; offers guidance
- ASE Technology Holding Co., Ltd (ASX) Tops Q3 EPS by 5c
- Preformed Line Products (PLPC) Tops Q3 EPS by 19c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share